GC CELL CORPORATION

144510KOSDAQOther scientific and technical services

GC CELL CORPORATION (144510, KOSDAQ) reported KRW 166bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202318840665541Consolidated
2024174-20-76578462Consolidated
2025166-14-274304190Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
20232.2%0%81.4%0%
2024-11.5%-43.4%79.9%-16.4%
2025-8.3%-165.2%62.7%-143.7%

Revenue moved -11.7% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 231bn
Close priceKRW 14,610
Listed shares15,800,344
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)806
Women285 (35.4%)
Average tenure5.2 years
Annual pay, menKRW 50,000,000
Annual pay, womenKRW 47,000,000
Pay ratio, women to men94%

Other companies in Other scientific and technical services

18 listed companies file under this classification. Showing 12.

See the whole Other scientific and technical services list →